Letter by de miguel castro et al regarding article, "platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: A time-dependent analysis of the gauging responsiveness with a verify now P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) Trial"

Circulation

Volumn 125, Issue 14, 2012, Pages

  De Miguel Castro, Antonio ^a   Nieto, Alejandro Diego ^b   De Prado, Armando Pérez ^b  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b Gerencia Regional de Salud de Castilla y León   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; PURINERGIC P2Y12 RECEPTOR; THROMBIN;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HUMAN; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STENT THROMBOSIS; THROMBOCYTE FUNCTION;

BLOOD PLATELETS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84859554584     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.075002     Document Type: Letter

References (5)

1. Price MJ, Angiolillo DJ, Teirstein PS, Lillie E, Manoukian SV, Berger PB, Tanguay JF, Cannon CP, Topol EJ. Platelet reactivity and cardiovas-cular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a Verify Now p2y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation. 2011;124:1132-1137.
2. Geisler T, Kapp M, Gohring-Frischholz K, Daub K, Dosch C, Bigalke B, Langer H, Herdeg C, Gawaz M. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease. Heart. 2008;94:743-747. (Pubitemid 351744692)
3. Angiolillo DJ, Bernardo E, Sabate M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernandez-Antolin R, Moreno R, Escaned J, Alfonso F, Banuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2007;50:1541-1547. (Pubitemid 47532327)
4. de Miguel Castro A, Cuellas Ramon C, Diego Nieto A, Samaniego Lampon B, Alonso Rodriguez D, Fernandez Vazquez F, Alonso Orcajo N, Carbonell de Blas R, Pascual Vicente C, Perez de Prado A. Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-st-segment elevation acute coronary syndrome. Rev Esp Cardiol. 2009;62:126-135.
5. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919-933.